NDC properties for NDC 9 55513-479
NDC item 55513047901
NDC 9 | 55513-479 |
---|---|
NDC 10 | 55513-479-01 |
NDC Item | 55513047901 |
packaging | 1 SYRINGE in 1 CARTON (55513-479-01) / .4 mL in 1 SYRINGE |
BLA | BLA761024 |
FDA SPL set id | 807577 |
Labeler | Amgen Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-08-14 |
Marketing status | ACTIVE |
NDC item 55513047902
NDC 9 | 55513-479 |
---|---|
NDC 10 | 55513-479-02 |
NDC Item | 55513047902 |
packaging | 2 SYRINGE in 1 CARTON (55513-479-02) / .4 mL in 1 SYRINGE |
BLA | BLA761024 |
FDA SPL set id | 807577 |
Labeler | Amgen Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2023-08-14 |
Marketing status | ACTIVE |
NDC item 72511047901
NDC 9 | 72511-479 |
---|---|
NDC 10 | 72511-479-01 |
NDC Item | 72511047901 |
BLA | BLA761024 |
FDA SPL set id | 828840 |
Labeler | Amgen USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2024-11-08 |
Marketing status | ACTIVE |
NDC item 72511047902
NDC 9 | 72511-479 |
---|---|
NDC 10 | 72511-479-02 |
NDC Item | 72511047902 |
packaging | 2 SYRINGE in 1 CARTON (72511-479-02) / .4 mL in 1 SYRINGE |
BLA | BLA761024 |
FDA SPL set id | 828840 |
Labeler | Amgen USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2024-11-08 |
Marketing status | ACTIVE |
NDC item 84612047901
NDC 9 | 84612-479 |
---|---|
NDC 10 | 84612-479-01 |
NDC Item | 84612047901 |
packaging | 1 SYRINGE in 1 CARTON (84612-479-01) / .4 mL in 1 SYRINGE |
BLA | BLA761024 |
FDA SPL set id | 858781 |
Labeler | Optum Health Solutions (Ireland) Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2025-01-01 |
Marketing status | ACTIVE |
NDC item 84612047902
NDC 9 | 84612-479 |
---|---|
NDC 10 | 84612-479-02 |
NDC Item | 84612047902 |
packaging | 2 SYRINGE in 1 CARTON (84612-479-02) / .4 mL in 1 SYRINGE |
BLA | BLA761024 |
FDA SPL set id | 858781 |
Labeler | Optum Health Solutions (Ireland) Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2025-01-01 |
Marketing status | ACTIVE |